Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis

被引:290
作者
Reid, Brian J. [1 ,2 ,3 ,4 ]
Li, Xiaohong [1 ]
Galipeau, Patricia C. [1 ,2 ]
Vaughan, Thomas L. [1 ,5 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA
[2] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA
[3] Univ Washington, Dept Med, Seattle, WA 98109 USA
[4] Univ Washington, Dept Genome Sci, Seattle, WA 98109 USA
[5] Univ Washington, Dept Epidemiol, Seattle, WA 98109 USA
基金
美国国家卫生研究院;
关键词
GASTROESOPHAGEAL-REFLUX DISEASE; BODY-MASS INDEX; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HIGH-GRADE DYSPLASIA; ENDOSCOPIC BIOPSY SURVEILLANCE; HELICOBACTER-PYLORI INFECTION; FLOW CYTOMETRIC ABNORMALITIES; LEUKOCYTE TELOMERE LENGTH; GENE-EXPRESSION PROFILES; SQUAMOUS-CELL CARCINOMA;
D O I
10.1038/nrc2773
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The public health importance of Barrett's oesophagus lies in its association with oesophageal adenocarcinoma. The incidence of oesophageal adenocarcinoma has risen at an alarming rate over the past four decades in many regions of the Western world, and there are indications that the incidence of this disease is on the rise in Asian populations in which it has been rare. Much has been learned of host and environmental risk factors that affect the incidence of oesophageal adenocarcinoma, and data indicate that patients with Barrett's oesophagus rarely develop oesophageal adenocarcinoma. Given that 95% of oesophageal adenocarcinomas arise in individuals without a prior diagnosis of Barrett's oesophagus, what strategies can be used to reduce late diagnosis of oesophageal adenocarcinoma?
引用
收藏
页码:87 / 101
页数:15
相关论文
共 220 条
[1]   Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis [J].
Abnet, C. C. ;
Freedman, N. D. ;
Kamangar, F. ;
Leitzmann, M. F. ;
Hollenbeck, A. R. ;
Schatzkin, A. .
BRITISH JOURNAL OF CANCER, 2009, 100 (03) :551-557
[2]   20-year outcomes following conservative management of clinically localized prostate cancer [J].
Albertsen, PC ;
Hanley, JA ;
Fine, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (17) :2095-2101
[3]   THE OESOPHAGUS LINED WITH GASTRIC MUCOUS MEMBRANE [J].
ALLISON, PR ;
JOHNSTONE, AS .
THORAX, 1953, 8 (02) :87-101
[4]   Attitudes, norms and controls influencing lifestyle risk factor management in general practice [J].
Ampt, Amanda J. ;
Amoroso, Cheryl ;
Harris, Mark F. ;
McKenzie, Suzanne H. ;
Rose, Vanessa K. ;
Taggart, Jane R. .
BMC FAMILY PRACTICE, 2009, 10
[5]   Mortality in Barrett's oesophagus: results from a population based study [J].
Anderson, LA ;
Murray, LJ ;
Murphy, SJ ;
Fitzpatrick, DA ;
Johnston, BT ;
Watson, RGP ;
McCarron, P ;
Gavin, AT .
GUT, 2003, 52 (08) :1081-1084
[6]   Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: Results from the FINBAR study [J].
Anderson, Lesley A. ;
Watson, R. G. Peter ;
Murphy, Seamus J. ;
Johnston, Brian T. ;
Comber, Harry ;
Mc Guigan, Jim ;
Reynolds, John V. ;
Murray, Liam J. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (10) :1585-1594
[7]   Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence [J].
Anderson, Lesley A. ;
Johnston, Brian T. ;
Watson, R. G. Peter ;
Murphy, Seamus J. ;
Ferguson, Heather R. ;
Comber, Harry ;
McGuigan, Jim ;
Reynolds, John V. ;
Murray, Liam J. .
CANCER RESEARCH, 2006, 66 (09) :4975-4982
[8]   The Association Between Alcohol and Reflux Esophagitis, Barrett's Esophagus, and Esophageal Adenocarcinoma [J].
Anderson, Lesley A. ;
Cantwell, Marie M. ;
Watson, R. G. Peter ;
Johnston, Brian T. ;
Murphy, Seamus J. ;
Ferguson, Heather R. ;
McGuigan, Jim ;
Comber, Harry ;
Reynolds, John V. ;
Murray, Liam J. .
GASTROENTEROLOGY, 2009, 136 (03) :799-805
[9]  
[Anonymous], LOC GOV ACT PREV CHI
[10]   Prospective study of cyclin D1 overexpression in Barrett's esophagus: Association with increased risk of adenocarcinoma [J].
Bani-Hani, K ;
Martin, IG ;
Hardie, LJ ;
Mapstone, N ;
Briggs, JA ;
Forman, D ;
Wild, CP .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (16) :1316-1321